Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)
China · Delayed Price · Currency is CNY 13.64
-0.94 (-6.45%)
Sep 10, 2026, 12:14 PM CST
SHE:002907 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 798.78 | 827.14 | 774.82 | 691.54 | 785.18 | 846.14 |
Revenue Growth | -0.01% | 6.75% | 12.04% | -11.93% | -7.20% | -4.12% |
Gross Profit Gross Profit Growth | 458.32 | 473.18 | 441.91 | 379.1 | 464.63 | 445.61 |
Operating Income Operating Income Growth | 56.14 | 52.8 | 60.9 | 27.78 | 97.59 | 94.95 |
Net Income Net Income Growth | 74.12 | 65.09 | 76.73 | 32.7 | 98.4 | 91.78 |
Earnings Per Share EPS Growth | 0.18 | 0.16 | 0.18 | 0.08 | 0.24 | 0.23 |
EPS Growth | -11.15% | -15.13% | 134.61% | -67.92% | 6.69% | -23.04% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Industry Pharmaceutical Industry Growth | 640.85 | 674.78 | 651.01 | 564.2 | 660.05 | 714.09 |
Pharmaceutical Commercial Pharmaceutical Commercial Growth | 144.52 | 139.71 | 111.26 | 113.88 | 112.64 | 121.24 |
Pharmaceutical Retail Pharmaceutical Retail Growth | 1.13 | 0.73 | 1.87 | 2.76 | 2.03 | 1.91 |
Unallocated Other Operations Unallocated Other Operations Growth | 12.28 | 11.93 | 10.68 | 10.7 | 10.47 | 8.91 |
Total Total Growth | 798.78 | 827.14 | 774.82 | 691.54 | 785.18 | 846.14 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 647.98 | 625.55 | 607.51 | 487.56 | 503.53 | 510.58 |
Total Debt Total Debt Growth | 3.4 | 3.74 | 0.13 | 0.28 | 0.17 | 251.12 |
Net Cash (Debt) Net Cash Growth | 644.58 | 621.82 | 607.39 | 487.28 | 503.36 | 259.45 |
Net Cash Growth | 6.30% | 2.38% | 24.65% | -3.19% | 94.01% | -8.68% |
Net Cash Per Share Net Cash Per Share Growth | 1.54 | 1.49 | 1.45 | 1.17 | 1.25 | 0.65 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 89.38 | 62.24 | 161.77 | 219.34 | 13.04 | 82.85 |
Capital Expenditures CapEx Growth | -28.82 | -14.56 | -16.15 | -92.82 | -60.62 | -56.64 |
Free Cash Flow Free Cash Flow Growth | 60.55 | 47.68 | 145.62 | 126.52 | -47.57 | 26.21 |
Free Cash Flow Growth | -45.62% | -67.25% | 15.09% | - | - | -60.85% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 57.38% | 57.21% | 57.03% | 54.82% | 59.17% | 52.66% |
Operating Margin | 7.03% | 6.38% | 7.86% | 4.02% | 12.43% | 11.22% |
Pretax Margin | 10.41% | 9.36% | 12.06% | 6.19% | 13.79% | 12.22% |
Profit Margin | 9.28% | 7.87% | 9.90% | 4.73% | 12.53% | 10.85% |
FCF Margin | 7.58% | 5.76% | 18.79% | 18.30% | -6.06% | 3.10% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.075 | 0.075 | 0.085 | 0.050 | 0.070 | 0.050 |
Dividend Per Share Growth | -11.76% | -11.77% | 70.00% | -28.57% | 40.00% | 78.57% |
Dividend Yield | 0.52% | 0.51% | 0.66% | 0.33% | 0.35% | 0.28% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 82.13 | 95.02 | 70.75 | 197.31 | 86.41 | 79.00 |
P/FCF Ratio | 100.55 | 129.70 | 37.28 | 50.99 | - | 276.62 |
PS Ratio | 7.62 | 7.48 | 7.01 | 9.33 | 10.83 | 8.57 |